The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway
about
Randomized control trial of topical clonidine for treatment of painful diabetic neuropathyTRPV1: on the road to pain reliefThe mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependenceActivation of mu opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) via β-arrestin-2-mediated cross-talkEndogenous opiates and behavior: 2006Morphine peripheral analgesia depends on activation of the PI3Kgamma/AKT/nNOS/NO/KATP signaling pathwayTransient receptor potential vanilloid type 1 channel may modulate opioid reward.HCN1 and HCN2 in Rat DRG neurons: levels in nociceptors and non-nociceptors, NT3-dependence and influence of CFA-induced skin inflammation on HCN2 and NT3 expressionBeta-endorphin 1-31 biotransformation and cAMP modulation in inflammationInflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain.Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization.The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensorFunctional role of peripheral opioid receptors in the regulation of cardiac spinal afferent nerve activity during myocardial ischemia.Intracellular signaling in primary sensory neurons and persistent pain.Sustained morphine treatment augments capsaicin-evoked calcitonin gene-related peptide release from primary sensory neurons in a protein kinase A- and Raf-1-dependent manner.Capsaicin-evoked iCGRP release from human dental pulp: a model system for the study of peripheral neuropeptide secretion in normal healthy tissue.Molecular assays for characterization of alternatively spliced isoforms of the u opioid receptor (MOR).Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade.Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics.New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view.Anti-nociceptive action of peripheral mu-opioid receptors by G-beta-gamma protein-mediated inhibition of TRPM3 channels.A Review on Potential Involvement of TRPV1 Channels in Ischemia-Reperfusion Injury.Morphine Reduces Expression of TRPV1 Receptors in the Amygdala but not in the Hippocampus of Male Rats.Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol.Molecular mechanism for opioid dichotomy: bidirectional effect of μ-opioid receptors on P2X₃ receptor currents in rat sensory neurones.G protein βγ subunits inhibit TRPM3 ion channels in sensory neurons.Agonist- and Ca2+-dependent desensitization of TRPV1 channel targets the receptor to lysosomes for degradation.Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia.Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain.Capsaicin presynaptically inhibits glutamate release through the activation of TRPV1 and calcineurin in the hippocampus of rats.
P2860
Q24621657-FF8C8F86-866D-47D1-B3C3-CDFB8C65ABE6Q24650367-4A9F43F5-D2D1-4EE8-BA4B-665B7D56CC8CQ26801420-20C8A51B-B6F5-42DD-A483-14FA65A0174AQ28541771-1F73358F-735D-44D4-925D-FEB3FDAFE5F6Q28752585-E0325357-DB48-4E9D-A087-8930A2B6ACF7Q33733102-A5A3C0B0-56F2-4E58-8123-A68C5DCE5BEFQ34068922-90712749-553F-47FD-92BE-9AF21A3E03CAQ34510373-61CB0977-2C0F-497E-BCAC-6C2C43223D67Q35117580-117D5152-790B-456E-B795-51D49C846679Q36734927-0AAB343C-3B12-440F-98AE-AA1859F77B18Q36744195-ECE7A24E-2EFE-4DA9-8F1E-305F33FAC83FQ37023861-E6C282E2-E760-4AB2-8F87-E6927CCECA40Q37054959-61FB5805-A4C0-4208-A16A-459DC23664B0Q37144214-DF9FDF6B-F121-4C0C-8610-E99EA5666BE9Q37312862-A786FA89-C0EB-4641-BE9A-AD65FDDBB369Q37381098-1DA82891-C24B-4282-8B62-CF77B127D0F2Q37718662-05EC760A-B7BC-446C-BE08-0E5811C49E91Q38088356-05B355E2-3E16-450E-907D-7B7F61C68B01Q38166804-F04CE7F6-6D2F-4F44-ADAA-6717310E042CQ38167283-AC9FCDD2-611F-4B37-BE82-2E321AABB684Q38615910-7E3B6A32-4AF8-48B0-AAC7-FCA8B1720C52Q39280219-7411A246-5192-4D27-BB38-D37986B6F320Q39765684-527102A2-50A2-4570-8501-DBCF62991180Q40083297-D7222839-A22C-422E-B804-10F5EAC60984Q40479525-8A288434-9458-4FD4-9FDC-E4A2241A9A6DQ41349997-69CF0642-2DD4-4EEE-9114-F0D27FB1411DQ42146851-EEC82810-CECC-4EA6-895F-61223F3883AFQ44341967-EF3303DC-2CA3-432E-ACCF-26DA38A23883Q45912640-75CF4D42-3611-470F-BDFD-80B2675D41DCQ46381656-54800B58-AAA9-44A3-907F-D9971B564BDB
P2860
The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The mu opioid agonist morphine ...... ndent protein kinase A pathway
@ast
The mu opioid agonist morphine ...... ndent protein kinase A pathway
@en
type
label
The mu opioid agonist morphine ...... ndent protein kinase A pathway
@ast
The mu opioid agonist morphine ...... ndent protein kinase A pathway
@en
prefLabel
The mu opioid agonist morphine ...... ndent protein kinase A pathway
@ast
The mu opioid agonist morphine ...... ndent protein kinase A pathway
@en
P2860
P50
P921
P356
P1433
P1476
The mu opioid agonist morphine ...... ndent protein kinase A pathway
@en
P2093
Bruce D Wyse
Peter J Cabot
P2860
P2888
P356
10.1186/1744-8069-2-22
P407
P577
2006-07-16T00:00:00Z
P5875
P6179
1008943750